药物相关性颌骨坏死17例发病特点与手术治疗分析
回顾性分析17例药物相关性颌骨坏死患者的临床资料,男9例、女8例,年龄(63.6±9.6)岁。原发疾病以恶性肿瘤为主(12例),最常见诱因为拔牙(11例),病变多位于下颌骨(10例)。全部行手术治疗,15例一期愈合,2例二次手术后愈合。
要点
- 拔牙是药物相关性颌骨坏死最常见诱因,下颌骨受累多于上颌骨
- 患者多有双膦酸盐用药史,部分合并抗血管生成药物
- 合适的手术治疗可获得较好临床效果
核心结论
- 拔牙可能是下颌骨药物相关性颌骨坏死的主要诱因,病变下颌骨多于上颌骨,合适的手术治疗可获较好效果。
研究设计与样本
- 回顾性分析2016年7月至2019年12月晋中市第一人民医院口腔颌面外科收治的17例药物相关性颌骨坏死患者临床资料,随访至少1年。
- 患者男9例、女8例,年龄(63.6±9.6)岁(43~82岁)。
主要发现
- 原发疾病为恶性肿瘤12例,骨质疏松5例。
- 诱因中拔牙11例,自发4例,不良可摘义齿2例。
- 病变位于上颌骨6例、下颌骨10例、上下颌骨同时累及1例。
- 给药时间(10.1±3.9)个月(3~18个月)。
- 17例均行手术治疗,15例创口一期愈合,2例术后8个月再次出现颌骨暴露,二次手术后愈合。
关键数值与推荐
- 静脉使用双膦酸盐16例,其中5例同时口服抑制血管生成药物;单独皮下注射地舒单抗1例。
临床怎么用
- 对使用双膦酸盐等药物且有拔牙史的患者应警惕药物相关性颌骨坏死,下颌骨病变多见,可考虑合适的手术治疗。
局限性
- 本文为单中心小样本回顾性描述性分析,未设对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To summarize the etiological characteristics and clinical treatment effects of 17 patients with medication-related osteonecrosis of the jaw (MRONJ). Methods: The clinical data of 17 patients with MRONJ admitted to the Department of Oral and Maxillofacial Surgery, the First People's Hospital of Jinzhong, Shanxi Province, from July 2016 to December 2019 were retrospectively analyzed, including 9 males and 8 females, aged (63.6±9.6) years old (43-82 years old). Descriptive analysis of the primary disease, onset factors, site of disease, clinical manifestations, treatment methods, and treatment effects was conducted through follow-up for at least 1 year. Results: Among the primary diseases of the 17 cases, 12 were malignant tumors, and 5 were osteoporosis. There were 13 cases with a history of a trigger event (tooth extraction or unsuited removable denture). Six cases occurred in the maxilla, 10 cases occurred in the mandible, and 1 case involved both the upper and lower jaws. For the most common medication used, bisphosphonate was used in 16 cases including 5 cases with concomitant use of angiogenesis-inhibiting drugs. There was 1 case resulted from receptor activator of NF-κB ligand (RANKL) monoclonal antibody application. The duration of medication application was (10.1±3.9) months (3-18 months). All 17 cases were treated surgically. Totally 15 patients healed well after surgical treatment and the other 2 patients, who had poor soft tissue healing after surgery, healed well after a second operation. Conclusions: Tooth extraction might be a major trigger factor for the onset of MRONJ in the mandible. The disease was more possibly occured in the mandible than in the maxilla. Appropriate surgical treatment could achieve a good clinical outcome. 目的: 对17例药物相关性颌骨坏死患者的发病因素特点和临床治疗效果进行初步总结和分析。 方法: 回顾2016年7月至2019年12月晋中市第一人民医院口腔颌面外科收治的17例药物相关性颌骨坏死患者临床资料,其中男性9例,女性8例,年龄(63.6±9.6)岁(43~82岁)。对其原发疾病、发病因素、发病部位、临床表现、治疗方法及效果进行随访至少1年,并进行描述性分析。 结果: 原发疾病为恶性肿瘤者12例,骨质疏松5例;诱因为拔牙者11例,自发4例,不良可摘义齿2例;发病部位位于上颌骨6例,下颌骨10例,上、下颌骨同时累及1例。17例患者均使用抗坏死类药物,其中单独皮下注射地舒单抗1例,静脉使用双膦酸盐16例,其中5例患者同时口服抑制血管生成药物;给药时间为(10.1±3.9)个月(3~18个月)。手术治疗17例,15例患者的创口一期愈合,2例患者于术后8个月再次出现颌骨暴露,行第二次手术治疗后创口愈合。 结论: 拔牙为药物相关性颌骨坏死的最常见诱因,下颌骨多于上颌骨,采取合适的手术治疗可达到较好的临床治疗效果。.
引用
- Hou W, Dong XT, Wu TT, et al. [Preliminary study on the etiological characteristics and clinical treatment of medication-related osteonecrosis of the jaws]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021. PMID: 34275221. doi:10.3760/cma.j.cn112144-20210120-00032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。